Triple therapy, SABA market growing

What is the cost and utilisation of the inhaler therapies market? Drug utilisation sub-committee investigates the numbers A PBS committee has considered whether reversion to Authority Required (telephone/online) may be required for single inhaler triple therapies for severe asthma based on their use. The drug utilisation sub-committee (DUSC) found that utilisation of Trelegy Ellipta more